DalsnaFinance › IPOs › Urogen Pharma LTD › IPO
UroGen Pharma Ltd. completed its initial public offering on NASDAQ on May 4, 2017, pricing at $13.00 a share.
| Ticker | URGN |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 4, 2017 |
| Offering price | $13.00 |
| Shares offered | 4,473,373 |
| Total raised | $58M |
UroGen Pharma Ltd. sold 4,473,373 shares at $13.00 each on NASDAQ. Multiplied out, that is $58.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $58 million total recorded for the deal.
UroGen Pharma Ltd. — quote, profile and latest news →
Source: SEC EDGAR filings for UroGen Pharma Ltd.. This page is general information, not investment advice.